| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Krystal Biotech, Inc. | $296.70 | 2.7% | $8.75B | 43.4 | 79.8% | — | Healthcare | 116.9% | 25.1% | ||
| 2 | Arcellx, Inc. | $115.07 | 0% | $6.73B | -28.3 | -102% | — | Healthcare | 117.4% | -79.4% | ||
| 3 | Legend Biotech Corporation | $28.57 | -1.3% | $5.28B | -8.9 | -67% | — | Healthcare | -9.2% | 64.2% | ||
| 4 | Sarepta Therapeutics, Inc. | $20.80 | -9.7% | $2.18B | -2.9 | 64.4% | — | Healthcare | -43.4% | -2.2% | ||
| 5 | Taysha Gene Therapies, Inc. | $6.67 | -4.4% | $1.92B | -19.6 | -7.3% | — | Healthcare | 251.1% | 3.4% | ||
| 6 | Capricor Therapeutics, Inc. | $33.94 | -1.3% | $1.55B | -29.5 | -69% | — | Healthcare | 392.6% | -52.1% | ||
| 7 | Immatics N.V. | $11.14 | -3.2% | $1.49B | 67.7 | -40.1% | — | Healthcare | 153.8% | -26.7% | ||
| 8 | uniQure N.V. | $24.15 | 5.8% | $1.49B | -7.0 | 20% | — | Healthcare | 140.1% | -10.4% | ||
| 9 | Tevogen Bio Holdings Inc. | $7.48 | 2.3% | $1.48B | -79.9 | 47.6% | — | Healthcare | -85.6% | — | ||
| 10 | Iovance Biotherapeutics, Inc. | $3.55 | -13.2% | $1.27B | -3.3 | 25.8% | — | Healthcare | 13.4% | 34.3% | ||
| 11 | Precigen, Inc. | $4.15 | -5.7% | $1.22B | -8.8 | -165.1% | — | Healthcare | 207.4% | 59.2% | ||
| 12 | Sana Biotechnology, Inc. | $3.50 | -3.8% | $918M | -3.0 | 30.7% | — | Healthcare | 105.9% | — | ||
| 13 | MeiraGTx Holdings plc | $9.68 | -2.2% | $779M | -4.6 | -61.1% | — | Healthcare | 78.9% | 96.8% | ||
| 14 | Solid Biosciences Inc. | $7.07 | -1.8% | $551M | -3.6 | 16.4% | — | Healthcare | 173% | — | ||
| 15 | REGENXBIO Inc. | $10.42 | 2% | $527M | -2.3 | 31% | — | Healthcare | 43.9% | 91.3% | ||
| 16 | Allogene Therapeutics, Inc. | $2.27 | -1.7% | $521M | -2.6 | 34.6% | — | Healthcare | 89.2% | -100% | ||
| 17 | 4D Molecular Therapeutics, Inc. | $9.93 | -4.7% | $519M | -4.1 | 16.4% | — | Healthcare | 218.3% | 370313% | ||
| 18 | Neurogene Inc. | $31.26 | -3.2% | $488M | -7.4 | -2.8% | — | Healthcare | 125.5% | -100% | ||
| 19 | Ocugen, Inc. | $1.44 | -1% | $487M | -6.3 | -25% | — | Healthcare | 117.5% | 8.8% | ||
| 20 | Lyell Immunopharma, Inc. | $20.06 | -3.8% | $468M | -1.2 | -919.7% | — | Healthcare | 138.2% | -52.3% | ||
| 21 | Candel Therapeutics, Inc. | $7.79 | 2.1% | $429M | -10.8 | 65% | — | Healthcare | 71.6% | — | ||
| 22 | Benitec Biopharma Inc. | $12.14 | -3.4% | $416M | -11.6 | 29.3% | — | Healthcare | -10.3% | — | ||
| 23 | Autolus Therapeutics plc | $1.61 | -5.6% | $410M | -1.8 | 30.6% | — | Healthcare | 30.5% | 406.7% | ||
| 24 | Cabaletta Bio, Inc. | $4.00 | 7.2% | $409M | -2.4 | 1.3% | — | Healthcare | 244.8% | — | ||
| 25 | Kyverna Therapeutics, Inc. | $9.30 | -1.8% | $407M | -2.8 | -21.2% | — | Healthcare | 360.4% | — | ||
| 26 | Rocket Pharmaceuticals, Inc. | $3.67 | -4.9% | $398M | -1.8 | 26.4% | — | Healthcare | -45.2% | — | ||
| 27 | Lexeo Therapeutics, Inc. Common Stock | $5.82 | -6.6% | $320M | -1.9 | 4.3% | — | Healthcare | 94.6% | — | ||
| 28 | Abeona Therapeutics Inc. | $5.77 | -4% | $318M | 5.7 | 154% | — | Healthcare | 9.5% | — | ||
| 29 | Artiva Biotherapeutics, Inc. | $12.52 | 1% | $307M | -2.4 | -18.5% | — | Healthcare | 496.2% | -100% | ||
| 30 | ProKidney Corp. | $1.88 | -4.1% | $299M | -3.7 | 17.5% | — | Healthcare | 193.6% | 1075% | ||
| 31 | Protara Therapeutics, Inc. | $5.37 | -5.1% | $288M | -4.0 | 44.6% | — | Healthcare | 60.3% | — | ||
| 32 | Fate Therapeutics, Inc. | $2.43 | 6.1% | $280M | -2.1 | 29.9% | — | Healthcare | 143% | -51.2% | ||
| 33 | Cellectis S.A. | $3.86 | -2.3% | $280M | -9.4 | 66.4% | — | Healthcare | 152.3% | 158.9% | ||
| 34 | Replimune Group, Inc. | $3.34 | -2.3% | $266M | -1.1 | -13.7% | — | Healthcare | -53.4% | — | ||
| 35 | Voyager Therapeutics, Inc. | $3.96 | -5% | $234M | -1.9 | -80.5% | — | Healthcare | 20.7% | -49.5% | ||
| 36 | Nkarta, Inc. | $3.15 | -5.1% | $223M | -2.0 | 26.6% | — | Healthcare | 68.4% | — | ||
| 37 | Century Therapeutics, Inc. | $2.31 | -1.3% | $202M | -16.5 | 91.6% | — | Healthcare | 342.7% | 1556.5% | ||
| 38 | Tenaya Therapeutics, Inc. | $0.85 | 7.4% | $184M | -1.4 | 53% | — | Healthcare | 88.6% | — | ||
| 39 | Caribou Biosciences, Inc. | $1.88 | -3.6% | $176M | -1.2 | -3% | — | Healthcare | 147.4% | -19% | ||
| 40 | TScan Therapeutics, Inc. | $1.21 | -3.2% | $157M | -1.2 | 11.9% | — | Healthcare | -11% | 84.4% | ||